Dr. Stewart Campbell This is Me

Education

 Web References

1. 1. www.acguniverse.org

   www.acguniverse.org/acgTOCSamp - [Cached]

   Published on: 5/7/2007   Last Visited: 5/7/2007

   Paul Sweetnam, PhD, Enoch Kim, PhD, Yingfei Yang, MS, Stewart Campbell, PhD, Pharmacology, Surface Logix, Inc., Brighton, MA

2. 2. Surface Logix - About Us -Leadership - Management

   www.surfacelogix.com/about_us/ - [Cached]

   Published on: 9/5/2006   Last Visited: 9/5/2006

   A. Stewart Campbell, Ph.D. Vice President, Preclinical Development
   
   Dr. Campbell joined Surface Logix in October 2000 as Director of Chemistry. He brings 10 years of pharmaceutical experience to Surface Logix. Prior to joining Surface Logix, Dr. Campbell held the positions of Director of Medicinal Chemistry and Director of Technical Operations at Insmed, Inc. In these roles at Insmed, Dr. Campbell was responsible for all aspects of chemistry, including medicinal and analytical chemistry, chemical development, and manufacturing of drug substance and drug product for clinical trials. In addition, he was responsible for non-clinical toxicology and bioanalysis supporting drug development. This role involved multiple interactions with the FDA. Prior to his tenure at Insmed, Dr. Campbell held a Research Scientist position in medicinal chemistry at Boehringer-Ingelheim Research in Montreal, where he actively investigated a variety of anti-viral targets. Dr. Campbell has a Ph.D. in organic and physical organic chemistry from Queen,s University (Canada) and conducted post-doctoral work in organic synthesis at Duke University.

3. 3. Surface Logix - News - SURFACE LOGIX TO PRESENT CLINICAL candidate for Dyslipidemia and Obesity AT

   www.surfacelogix.com/news/news - [Cached]

   Published on: 11/18/2005   Last Visited: 1/17/2008

   Additional results for SLx-2101 from Surface Logix' preclinical program will be presented by Dr. Stewart Campbell , Vice President of Chemistry at Surface Logix in a SMSNA poster session on Saturday, November 19.